The Genetic Link Between Diabetes and Atherosclerosis

Area of Science:

• Genetics
• Cardiovascular Medicine
• Endocrinology

Background:

• Epidemiological studies suggest a link between diabetes and increased risk of atherothrombotic coronary artery disease (CAD).
• Clinical trial results have not consistently supported this association, creating a discrepancy.
• Understanding the shared genetic basis can clarify these relationships.

Purpose of the Study:

• To investigate the shared genetic architecture of diabetes and atherothrombotic CAD using genome-wide association studies (GWAS).
• To assess potential causal relationships between diabetes and CAD using Mendelian randomization (MR).
• To explore the genetic links between statin use, diabetes risk, and HMG-CoA reductase (HMGCR) activity.

Main Methods:

• Genome-wide association studies (GWAS) to identify shared genetic loci.
• Mendelian randomization (MR) analyses to infer causality.
• Analysis of genetic variants related to HMG-CoA reductase (HMGCR) activity.

Main Results:

• GWAS identified 16 novel loci associated with both diabetes and atherothrombotic CAD.
• MR analyses demonstrated that diabetes is an independent risk factor for CAD (OR: 1.63, 95% CI: 1.23-2.07).
• Genetically lower HMGCR activity was associated with a modest increase in diabetes risk (OR per allele: 1.02, 95% CI: 1.00-1.05).

Conclusions:

• Genetic studies, including GWAS and MR, are valuable for understanding the mechanistic relationships between diabetes, dysglycemia, and atherosclerotic vascular disease.
• Diabetes is causally linked to an increased risk of CAD.
• Genetic insights into HMGCR activity highlight biological mechanisms connecting diabetes and statin therapy.